GLP-1 News
The latest research, community stories, and updates from across the GLP-1 world.
This Week
Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices - UCHealth
Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices UCHealth
Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap
(MedPage Today) -- Investigational apitegromab -- a selective myostatin activation inhibitor -- effectively preserved lean mass when combined with tirzepatide (Zepbound) in a…
Semaglutide and aging: New study finds benefits beyond weight loss - Medical News Today
Semaglutide and aging: New study finds benefits beyond weight loss Medical News Today
Gilead and Merck’s latest trial success and flop
AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
CDC Trust Falls Sharply; Watchdog Flags Medicaid Gaps; Drug Targets 'Ozempic Butt'
(MedPage Today) -- Note that some links may require registration or subscription. Only 50% of the public said they now trust health recommendations from the CDC, down from 77% in…
New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy - HealthDay
New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy HealthDay
GLP-1s appear to protect against cancer. Researchers are trying to figure out how - NPR
GLP-1s appear to protect against cancer. Researchers are trying to figure out how NPR
Only 12 injections a year? New obesity drug could change weight loss treatment - The Indian Express
Only 12 injections a year? New obesity drug could change weight loss treatment The Indian Express
Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests - Reuters
Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests Reuters
Tolerability Concerns for GLP-1/Glucagon Agonist in Obesity, MASLD
(MedPage Today) -- NEW ORLEANS -- Treatment with survodutide led to significant weight loss and reductions in liver fat in phase III trials of obesity and metabolic…
GLP-1 Drugs 2026: ADA Sessions Close as New Standards End Single-Goal Diabetes Care - Tech Times
GLP-1 Drugs 2026: ADA Sessions Close as New Standards End Single-Goal Diabetes Care Tech Times
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
Large Study Links GLP-1s to Lower Risk of Multiple Cancers - MedPage Today
Large Study Links GLP-1s to Lower Risk of Multiple Cancers MedPage Today
Large Study Links GLP-1s to Lower Risk of Multiple Cancers
(MedPage Today) -- Patients taking GLP-1 receptor agonists for obesity had a 41% lower risk of obesity-related cancers as compared with patients treated with diet or exercise, a…
GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials
(MedPage Today) -- NEW ORLEANS -- A fixed-dose combination of novel amylin analog cagrilintide and semaglutide, given once weekly, lowered blood glucose and weight in various…
Monthly GLP-1 for Obesity Promising as More Manageable Alternative
(MedPage Today) -- NEW ORLEANS -- Injections of an ultra-long-acting investigational GLP-1 agonist led to significant weight loss in people with overweight or obesity, with…
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
At a big meeting for weight loss drugs, Lilly’s “triple G” therapy set a new standard as lingering doubts surrounded other competing treatments.
New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs - BBC
New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs BBC
India's GLP-1 market enters slower growth phase after semaglutide surge - Business Standard
India's GLP-1 market enters slower growth phase after semaglutide surge Business Standard
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide
How Long Has Mounjaro Been on the Market? - Healthline
How Long Has Mounjaro Been on the Market? Healthline
GLP-1 Weight-Loss Drugs Linked to 41% Lower Cancer Risk, New Study Finds - bgnes.com
GLP-1 Weight-Loss Drugs Linked to 41% Lower Cancer Risk, New Study Finds bgnes.com
GLP-1 RAs Effective for Weight Loss in Rheumatic and Musculoskeletal Diseases - Rheumatology Advisor
GLP-1 RAs Effective for Weight Loss in Rheumatic and Musculoskeletal Diseases Rheumatology Advisor
Earlier
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.
Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
(MedPage Today) -- NEW ORLEANS -- Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in…
Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control
(MedPage Today) -- NEW ORLEANS -- Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international…
Popular weight loss drug may slow down biological aging: Study - NewsNation
Popular weight loss drug may slow down biological aging: Study NewsNation
STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drug
Boehringer Ingelheim’s obesity drug showed promise in cutting liver fat, but it was less impressive at overall weight loss, new data shows.
ADA26: Pfizer builds momentum for Metsera GLP-1 bet amid slew of Phase III starts this year - FirstWord Pharma
ADA26: Pfizer builds momentum for Metsera GLP-1 bet amid slew of Phase III starts this year FirstWord Pharma
Penn Medicine Reports 30% Drop in Breast Cancer Risk with Ozempic and Wegovy - Medical Daily
Penn Medicine Reports 30% Drop in Breast Cancer Risk with Ozempic and Wegovy Medical Daily
Stanford Study Identifies Why Ozempic and Wegovy Don't Work in About 1 in 10 Patients - Medical Daily
Stanford Study Identifies Why Ozempic and Wegovy Don't Work in About 1 in 10 Patients Medical Daily
Why Some People Switch from Semaglutide to Tirzepatide - AOL.com
Why Some People Switch from Semaglutide to Tirzepatide AOL.com
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.
STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk - ScienceDaily
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk ScienceDaily
The next goal for weight loss drugs? Fewer injections - NBC News
The next goal for weight loss drugs? Fewer injections NBC News
STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.
A gastroenterologist reflects on Ozempic, Wegovy, weight loss and the gut microbiome - UW Magazine
A gastroenterologist reflects on Ozempic, Wegovy, weight loss and the gut microbiome UW Magazine
The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting - The Washington Post
The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting The Washington Post
Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
(MedPage Today) -- CHICAGO -- A study of women undergoing breast imaging showed a significantly lower incidence of breast cancer in those who had a history of treatment with…
Generic semaglutide is now available in Canada. Where is the medication available and is it actually cheaper? - The Globe and Mail
Generic semaglutide is now available in Canada. Where is the medication available and is it actually cheaper? The Globe and Mail
GLP-1 drugs like Ozempic, Wegovy may help lower breast cancer risk by 30% - Medical News Today
GLP-1 drugs like Ozempic, Wegovy may help lower breast cancer risk by 30% Medical News Today
GLP-1s Could Replace the Need for Knee Replacement Surgery - Drug Topics
GLP-1s Could Replace the Need for Knee Replacement Surgery Drug Topics
Wegovy and Ozempic seen to slow down biological ageing markers in HIV adults - Labmate Online
Wegovy and Ozempic seen to slow down biological ageing markers in HIV adults Labmate Online
Tirzepatide vs Semaglutide For Weight Loss: What’s The Difference? - Forbes
Tirzepatide vs Semaglutide For Weight Loss: What’s The Difference? Forbes
Why Canadians can now get cheaper generic Ozempic - and Americans can't - BBC
Why Canadians can now get cheaper generic Ozempic - and Americans can't BBC
Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30% - Healthline
Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30% Healthline
An Experimental Weight Loss Drug Could Outperform Ozempic. Here’s What Makes It Different. - Health: Trusted and Empathetic Health and Wellness Information
An Experimental Weight Loss Drug Could Outperform Ozempic. Here’s What Makes It Different. Health: Trusted and Empathetic Health and Wellness Information
NewLimit’s $435M megaround; Lilly’s busy dealmaking week
The anti-aging biotech has secured one of the year’s biggest venture fundings to bring its first drug into testing. Elsewhere, Lilly nabbed a “GLP-2” obesity drug and Praxis…
Ozempic may be reshaping the brain, scientists say - independentonsaturday.co.za
Ozempic may be reshaping the brain, scientists say independentonsaturday.co.za
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose - ScienceDaily
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose ScienceDaily
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found
Injecting compliance: A tightening regulatory grip on GLP-1 medicines? - vwv.co.uk
Injecting compliance: A tightening regulatory grip on GLP-1 medicines? vwv.co.uk
GLP-1 drugs may have a beneficial effect across many types of cancer - The Hindu
GLP-1 drugs may have a beneficial effect across many types of cancer The Hindu
FOCUS-GLP-1 drugs may have a beneficial effect across many types of cancer - Lee News Central
FOCUS-GLP-1 drugs may have a beneficial effect across many types of cancer Lee News Central
GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30% - HealthDay
GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30% HealthDay
DOJ sues OhioHealth over alleged anticompetitive hospital contracts; Novo to slash Ozempic, Wegovy prices up to 50% in 2027; lightweight ‘exoskeleton’ helps stroke survivors walk – Morning Medical Update - Medical Economics
DOJ sues OhioHealth over alleged anticompetitive hospital contracts; Novo to slash Ozempic, Wegovy prices up to 50% in 2027; lightweight ‘exoskeleton’ helps stroke survivors walk…
GLP-1 agonists linked to significantly lower long-term risk of knee replacement - Medical Xpress
GLP-1 agonists linked to significantly lower long-term risk of knee replacement Medical Xpress
GLP-1 Drugs Cut Need for Knee Replacement
(MedPage Today) -- People with knee osteoarthritis (OA) who used GLP-1 receptor agonists were less likely to undergo knee replacement surgery, an analysis of a large records…
Omnipod Pod Recall; Afrezza OK'd for Kids 6 and Up; CVS to Cover Zepbound Again
(MedPage Today) -- Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully…
Semaglutide is used for weight loss but may benefit kidneys and heart - Australian Broadcasting Corporation
Semaglutide is used for weight loss but may benefit kidneys and heart Australian Broadcasting Corporation
GLP-1 Drugs Beyond Weight Loss: What’s Proven, Promising and Still Hype? - vocal.media
GLP-1 Drugs Beyond Weight Loss: What’s Proven, Promising and Still Hype? vocal.media
AI Finds Potential Ozempic Side Effects Hidden in an Unexpected Data Source - ScienceAlert
AI Finds Potential Ozempic Side Effects Hidden in an Unexpected Data Source ScienceAlert
Embody GLP-1 Reviews - Is It Worth Trying in 2026? Pricing, Safety, Side Effects, and Results - Muddy River News
Embody GLP-1 Reviews - Is It Worth Trying in 2026? Pricing, Safety, Side Effects, and Results Muddy River News
Study of 400,000 Reddit Posts Reveals Possible New Ozempic Side Effects Linked to GLP-1 Drugs - Tech Times
Study of 400,000 Reddit Posts Reveals Possible New Ozempic Side Effects Linked to GLP-1 Drugs Tech Times
Study of 400,000 Reddit Posts Reveals Possible New Ozempic Side Effects Linked to GLP-1 Drugs - Tech Times
Study of 400,000 Reddit Posts Reveals Possible New Ozempic Side Effects Linked to GLP-1 Drugs Tech Times
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype? - The Conversation
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype? The Conversation
How digital platforms and policy shifts reshape GLP-1 affordability - Medical Xpress
How digital platforms and policy shifts reshape GLP-1 affordability Medical Xpress
Wegovy Lawsuit 2025-26 | Gastroparesis & Wegovy Settlements - Sokolove Law
Wegovy Lawsuit 2025-26 | Gastroparesis & Wegovy Settlements Sokolove Law
Weight loss drugs and the eye worry, this study points to a surprising upside - Earth.com
Weight loss drugs and the eye worry, this study points to a surprising upside Earth.com
Weight loss drug retatrutide use requires strict supervision, doctor says - NewsNation
Weight loss drug retatrutide use requires strict supervision, doctor says NewsNation
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
STAT+: Medicare still won’t say how much covering obesity drugs will cost
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
Ozempic Lawsuit 2026: Stomach Paralysis, Vision Loss & Legal Options - Consumer Notice
Ozempic Lawsuit 2026: Stomach Paralysis, Vision Loss & Legal Options Consumer Notice
Serena Williams is returning to tennis — and bringing the GLP-1 debate with her - Tennis.com
Serena Williams is returning to tennis — and bringing the GLP-1 debate with her Tennis.com
Can Mounjaro Cause Constipation? Yes, Try This for Relief - GoodRx
Can Mounjaro Cause Constipation? Yes, Try This for Relief GoodRx
Mounjaro vs. Ozempic: Differences, Weight Loss, & More - GoodRx
Mounjaro vs. Ozempic: Differences, Weight Loss, & More GoodRx
Ozempic, Wegovy can lead to temporary hair loss: Doctor | Morning in America - WIVT - News 34
Ozempic, Wegovy can lead to temporary hair loss: Doctor | Morning in America WIVT - News 34
Which vaccines will curb the Ebola outbreak? WHO debates
The growing Ebola outbreak, the unknowns of microdosing GLP-1s, and more health news from Morning Rounds
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.
A GLP-1 Pill May Help You Keep Weight Off After Stopping Wegovy or Zepbound - Verywell Health
A GLP-1 Pill May Help You Keep Weight Off After Stopping Wegovy or Zepbound Verywell Health
People Who Stop Ozempic Often Don’t Gain the Weight Back - SciTechDaily
People Who Stop Ozempic Often Don’t Gain the Weight Back SciTechDaily
14 New Weight Loss Drugs - GoodRx
14 New Weight Loss Drugs GoodRx
Can’t Refill Your Ozempic? 7 Ozempic Alternatives - GoodRx
Can’t Refill Your Ozempic? 7 Ozempic Alternatives GoodRx
GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding
(MedPage Today) -- A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain medication use and lower risks for pancreatic interventions,…
Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro - PR Newswire
Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro PR Newswire
Ozempic And Other GLP-1 Drugs May Be Altering The Brain, researchers say - International Business Times
Ozempic And Other GLP-1 Drugs May Be Altering The Brain, researchers say International Business Times
CVS obesity drug deal puts Lilly on equal footing with Novo
The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.
CVS Caremark to cover Zepbound again after lawsuit, widespread backlash - LiveNOW from FOX
CVS Caremark to cover Zepbound again after lawsuit, widespread backlash LiveNOW from FOX
STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more.
Ozempic may be reshaping the brain, scientists say - The Washington Post
Ozempic may be reshaping the brain, scientists say The Washington Post
GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study - New York Post
GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study New York Post
Can GLP-1 Medications Slow Cancer Progression? - Cancer Health
Can GLP-1 Medications Slow Cancer Progression? Cancer Health
Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care - PR Newswire
Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes…
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash - NBC News
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash NBC News
More Health Insurance Companies May Soon Cover the GLP-1 Obesity Drugs Zepbound and Foundayo - Everyday Health
More Health Insurance Companies May Soon Cover the GLP-1 Obesity Drugs Zepbound and Foundayo Everyday Health
Five Things to Know About Weight-Loss Drugs and IBD
(MedPage Today) -- As gastroenterologists seek better therapies for inflammatory bowel disease (IBD), they're closely watching the evolving data on GLP-1 receptor agonists. Could…
Best GLP-1 Programs & Weight Loss Medication Providers - Forbes
Best GLP-1 Programs & Weight Loss Medication Providers Forbes
Best Online Tirzepatide Programs (2026): Where To Buy Tirzepatide - Forbes
Best Online Tirzepatide Programs (2026): Where To Buy Tirzepatide Forbes
6 Best Affordable Online Tirzepatide Providers (2026) - Forbes
6 Best Affordable Online Tirzepatide Providers (2026) Forbes
Mounjaro vs. Ozempic: What’s The Difference? - Forbes
Mounjaro vs. Ozempic: What’s The Difference? Forbes
6 Best Affordable Online GLP-1 Providers (2026) - Forbes
6 Best Affordable Online GLP-1 Providers (2026) Forbes
Ozempic, Wegovy And More: Why GLP-1 Weight Loss Drugs Affect Every Body Differently - News18
Ozempic, Wegovy And More: Why GLP-1 Weight Loss Drugs Affect Every Body Differently News18
Better than Ozempic? Scientists say new experimental ‘Trojan horse’ drug could be the future of weight lo - The Times of India
Better than Ozempic? Scientists say new experimental ‘Trojan horse’ drug could be the future of weight lo The Times of India
From Rybelsus to the Ozempic Pill: What Pharmacists Need to Know About the Next Generation of Oral Semaglutide - Pharmacy Times
From Rybelsus to the Ozempic Pill: What Pharmacists Need to Know About the Next Generation of Oral Semaglutide Pharmacy Times
Drug Sheds 28% of Weight; Universal T1D Screening? Lilly Accuses Church of Fraud
(MedPage Today) -- Patients with obesity dropped a mean 28% of their body weight with a 12-mg dose of the investigational triple-receptor agonist retatrutide over 80 weeks in a…
Zepbound Blindness Lawsuit [2026 Update] - robertkinglawfirm.com
Zepbound Blindness Lawsuit [2026 Update] robertkinglawfirm.com
Popular weight loss drugs Wegovy, Ozempic linked to rare 'eye stroke' - Deccan Herald
Popular weight loss drugs Wegovy, Ozempic linked to rare 'eye stroke' Deccan Herald
STAT+: Five biotech news updates to stay on top of today
Eli Lilly spends more of its GLP-1 cash, Humira's masterclass in monopoly, and more updates from The Readout
Trump's Medical Exam; Ebola Outpacing Response; Eating Disorders and GLP-1s
(MedPage Today) -- Note that some links may require registration or subscription. President Donald Trump is expected to have a medical exam today at Walter Reed National Military…
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics - Global News
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics Global News
Zepbound Side Effects: Risks, Injuries & Lawsuit Updates - Motley Rice
Zepbound Side Effects: Risks, Injuries & Lawsuit Updates Motley Rice
Popular weight loss drug Wegovy linked to eye stroke - a condition that can leave you blind forever study warns - TheHealthSite
Popular weight loss drug Wegovy linked to eye stroke - a condition that can leave you blind forever study warns TheHealthSite
iDexis rejects Sahpra claims in GLP-1 weight‑loss drug recall order - Business Day
iDexis rejects Sahpra claims in GLP-1 weight‑loss drug recall order Business Day
Generic versions of Ozempic coming 'any day' to Alberta pharmacies - CBC
Generic versions of Ozempic coming 'any day' to Alberta pharmacies CBC
Ozempic personality: Doctors on whether weight-loss drugs affect emotions and motivation - The Indian Express
Ozempic personality: Doctors on whether weight-loss drugs affect emotions and motivation The Indian Express
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus - ScienceDaily
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus ScienceDaily
Weight loss drugs and nutrient deficiency: What nutrients are GLP-1 users lacking? - The Times of India
Weight loss drugs and nutrient deficiency: What nutrients are GLP-1 users lacking? The Times of India
Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them - HuffPost
Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them HuffPost
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects - ScienceDaily
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects ScienceDaily
Is 'Ozempic Personality' Real? Experts Weigh In - dailyvoice.com
Is 'Ozempic Personality' Real? Experts Weigh In dailyvoice.com
People with eating disorders are taking GLP-1s, and doctors are alarmed - The Washington Post
People with eating disorders are taking GLP-1s, and doctors are alarmed The Washington Post
Wegovy linked to rare “eye stroke” that can cause sudden blindness - ScienceDaily
Wegovy linked to rare “eye stroke” that can cause sudden blindness ScienceDaily
Popular weight loss drugs like Wegovy may also target arthritis inflammation - ScienceDaily
Popular weight loss drugs like Wegovy may also target arthritis inflammation ScienceDaily
Microdosing GLP-1 and Accutane: What Does It Mean—and Does It Work? - Yale Medicine
Microdosing GLP-1 and Accutane: What Does It Mean—and Does It Work? Yale Medicine
Novo Nordisk A/S stock (DK0060534915): Wegovy and Ozempic momentum after latest earnings - AD HOC NEWS
Novo Nordisk A/S stock (DK0060534915): Wegovy and Ozempic momentum after latest earnings AD HOC NEWS
Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial - The Indian Express
Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types - MedPage Today
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types MedPage Today
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
(MedPage Today) -- CHICAGO -- Use of GLP-1 receptor agonists in patients with four solid tumor types was significantly associated with lower rates of progression to metastatic…
New drug retatrutide shows dramatic weight loss in clinical trial - Good Morning America
New drug retatrutide shows dramatic weight loss in clinical trial Good Morning America
Opinion: Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t. - MarketWatch
Opinion: Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t. MarketWatch
Stoking Sexual Arousal and Desire: GLP-1s, Nerve Stimulation, 'Scream Cream'
(MedPage Today) -- WASHINGTON -- Interest in GLP-1 receptor agonists as a potential aid to sexual desire and arousal disorders took off in the field of sexual medicine -- and…
Mounjaro NAION Lawsuit Claims Side Effects Led to Permanent Vision Loss - AboutLawsuits.com
Mounjaro NAION Lawsuit Claims Side Effects Led to Permanent Vision Loss AboutLawsuits.com
Experimental weight loss drug retatrutide shows dramatic weight loss in clinical trial - ABC News - Breaking News, Latest News and Videos
Experimental weight loss drug retatrutide shows dramatic weight loss in clinical trial ABC News - Breaking News, Latest News and Videos
Lilly’s triple-acting obesity drug hits goal in Phase 3 trial
Participants who stayed on the drug lost around one-quarter of their body weight, potentially setting a new benchmark for rivals like Novo Nordisk.
STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
Eli Lilly reported that in a late-stage trial, its next-generation obesity drug led to weight loss approaching the effectiveness seen with bariatric surgery
STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
A next-gen Eli Lilly obesity drug led to bariatric-surgery levels of weight loss in a study, but also saw patients dropping out because of side effects.
Mounjaro Side Effects: Common, Serious & FDA Warnings - Drugwatch.com
Mounjaro Side Effects: Common, Serious & FDA Warnings Drugwatch.com
Retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial - Everyday Health
Retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial Everyday Health
Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story? - Yahoo Finance
Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story? Yahoo Finance
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk - ScienceDaily
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk ScienceDaily
Can You Take Mounjaro and Metformin Together? - GoodRx
Can You Take Mounjaro and Metformin Together? GoodRx
Victoza vs. Mounjaro: 7 Differences to Know - GoodRx
Victoza vs. Mounjaro: 7 Differences to Know GoodRx
Men and Women May Respond Differently to GLP-1s — Learn How - Everyday Health
Men and Women May Respond Differently to GLP-1s — Learn How Everyday Health
Weight Loss: GLP-1 Drugs Like Ozempic, Mounjaro Can Quiet 'Food Noise' - Healthline
Weight Loss: GLP-1 Drugs Like Ozempic, Mounjaro Can Quiet 'Food Noise' Healthline
As Novo’s patent expires, GLP-1 generics go global - Healthcare Brew
As Novo’s patent expires, GLP-1 generics go global Healthcare Brew
Generic semaglutide to hit Canadian pharmacies this week at lower cost - Global News
Generic semaglutide to hit Canadian pharmacies this week at lower cost Global News
4 Retatrutide Side Effects You Should Know About - GoodRx
4 Retatrutide Side Effects You Should Know About GoodRx
Generic Ozempic is now on Canadian shelves. Is it the same as the brand name version? - CBC
Generic Ozempic is now on Canadian shelves. Is it the same as the brand name version? CBC
Tirzepatide Side Effects: Blood Clots, Gastroparesis & More - Motley Rice
Tirzepatide Side Effects: Blood Clots, Gastroparesis & More Motley Rice
Weight loss drugs Ozempic and Mounjaro also lower heart and kidney disease risks, says study - Moneycontrol.com
Weight loss drugs Ozempic and Mounjaro also lower heart and kidney disease risks, says study Moneycontrol.com
GLP-1 injections may seem like a lifelong commitment, but a case series at Scripps suggests that, after reaching a plateau, some patients maintained their results by spacing out their doses of semaglutide or tirzepatide to every two weeks or longer - OkDiario
GLP-1 injections may seem like a lifelong commitment, but a case series at Scripps suggests that, after reaching a plateau, some patients maintained their results by spacing out…
GLP-1s vs Bariatric Surgery; Obesity Trends Reversing; Creatine for Menopause?
(MedPage Today) -- GLP-1 medication use increased by 140.4% from 2022 to 2024 while metabolic bariatric surgery utilization declined by 34.1%, national insurance data indicated.…
STAT+: A new ranking of pharma companies by R&D performance
Maryland drug board to cap price of Ozempic, TrumpRx partners with Cuban, GoodRx, and more biotech news
GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men - MedPage Today
GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men MedPage Today
Semaglutide For Weight Loss: Risks, Side Effects And More - Forbes
Semaglutide For Weight Loss: Risks, Side Effects And More Forbes
Do GLP-1 Weight-Loss Drugs Dull Emotions? ‘Ozempic Personality’ Concerns Patients, Doctors - TODAY.com
Do GLP-1 Weight-Loss Drugs Dull Emotions? ‘Ozempic Personality’ Concerns Patients, Doctors TODAY.com
People who lost the most weight on Ozempic saw huge health benefits - ScienceDaily
People who lost the most weight on Ozempic saw huge health benefits ScienceDaily
Ozempic and simple aging can melt away important muscle from your body - Scientific American
Ozempic and simple aging can melt away important muscle from your body Scientific American
Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month - BioSpace
Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month BioSpace
STAT+: Maryland state affordability board places a price cap on Ozempic
Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the price of Ozempic.
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how - MSN
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how MSN
People Who Use Ozempic for Weight Loss Are Judged More Harshly Than Those Who Stay Obese - ZME Science
People Who Use Ozempic for Weight Loss Are Judged More Harshly Than Those Who Stay Obese ZME Science
Eli Lilly (LLY) Is the Face of the Obesity Drug Boom. Has the Market Already Priced It In? - TipRanks
Eli Lilly (LLY) Is the Face of the Obesity Drug Boom. Has the Market Already Priced It In? TipRanks
Beyond Weight Loss: Can GLP-1/GIP Drugs Curb Alcohol Cravings? - The People's Pharmacy
Beyond Weight Loss: Can GLP-1/GIP Drugs Curb Alcohol Cravings? The People's Pharmacy
GLP-1 Drugs Like Ozempic, Wegovy May Help Lower Blood Pressure - Healthline
GLP-1 Drugs Like Ozempic, Wegovy May Help Lower Blood Pressure Healthline
Ozempic (Semaglutide): Side Effects, Risks & FDA Warnings - Drugwatch.com
Ozempic (Semaglutide): Side Effects, Risks & FDA Warnings Drugwatch.com
GLP-1 Telehealth Programs in 2026: A Practical Guide to Finding the Right Fit - WorldHealth.net
GLP-1 Telehealth Programs in 2026: A Practical Guide to Finding the Right Fit WorldHealth.net
Ozempic, Wegovy maker Novo Nordisk teams up with OpenAI for AI drug discovery - MSN
Ozempic, Wegovy maker Novo Nordisk teams up with OpenAI for AI drug discovery MSN
Tirzepatide Erectile Dysfunction: What the Evidence Shows for Metabolic Health - stat.gov.pl
Tirzepatide Erectile Dysfunction: What the Evidence Shows for Metabolic Health stat.gov.pl
Do GLP-1 cause erectile dysfunction? - stat.gov.pl
Do GLP-1 cause erectile dysfunction? stat.gov.pl
Tirzepatide (Zepbound) for the Treatment of Obesity - American Academy of Family Physicians | AAFP
Tirzepatide (Zepbound) for the Treatment of Obesity American Academy of Family Physicians | AAFP
Orforglipron vs. Tirzepatide: What Are the Major Differences? - GoodRx
Orforglipron vs. Tirzepatide: What Are the Major Differences? GoodRx
19 Ozempic and Wegovy Side Effects You Should Know About - GoodRx
19 Ozempic and Wegovy Side Effects You Should Know About GoodRx
GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis
(MedPage Today) -- Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults with difficult-to-treat plaque…
GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients - Review of Optometry
GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients Review of Optometry
Do GLP-1s really matter? - Benefits and Pensions Monitor
Do GLP-1s really matter? Benefits and Pensions Monitor
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how - MSN
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how MSN
Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System - Cureus
Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System Cureus
Mounjaro Eye Side Effects Lawsuit [2026 Update] - robertkinglawfirm.com
Mounjaro Eye Side Effects Lawsuit [2026 Update] robertkinglawfirm.com
GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients - Review of Optometry
GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients Review of Optometry
Is Tirzepatide Better Than Semaglutide For Weight Loss? A Comparison [NGw2E9uiP2n] - qsr.mlit.go.jp
Is Tirzepatide Better Than Semaglutide For Weight Loss? A Comparison [NGw2E9uiP2n] qsr.mlit.go.jp
GLP-1s and Hepatic Events; 'Shame, Taboo, Hygiene'; Treating Late-Onset IBD
(MedPage Today) -- Among U.S. adults with diabetes and steatotic liver disease in the All of Us cohort, new use of a GLP-1 receptor agonist was linked with a 38% to 42% lower risk…
Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk - AboutLawsuits.com
Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk AboutLawsuits.com
Canadians can now get Ozempic and Wegovy delivered to their door - Benefits and Pensions Monitor
Canadians can now get Ozempic and Wegovy delivered to their door Benefits and Pensions Monitor
The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors - Yahoo Creators
The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors Yahoo Creators
GLP-1 ‘Maintenance Dosing’ Could Be the Key to Keeping Weight Off - Everyday Health
GLP-1 ‘Maintenance Dosing’ Could Be the Key to Keeping Weight Off Everyday Health
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how - MSN
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how MSN
GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition
(MedPage Today) -- Two patients taking the GLP-1 receptor agonist dulaglutide (Trulicity) developed choroidal lymphoid hyperplasia (CLH), a rare, benign condition of the uveal…
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how - unpublished.ca
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s how unpublished.ca
Canada approves generic semaglutide from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent - drugdiscoverytrends.com
Canada approves generic semaglutide from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent drugdiscoverytrends.com
Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead - TradingView
Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead TradingView
Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead - Yahoo Finance
Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead Yahoo Finance
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss
A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down…
FDA Proposes to Exclude GLP-1s From 503B Bulk List - Drug Topics
FDA Proposes to Exclude GLP-1s From 503B Bulk List Drug Topics
STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and more
FDA Commissioner Marty Makary is resigning, and Kyle Diamantas, the agency's top food regulator, will step in as acting commissioner
Eli Lilly stock (US5324571083): Long-term weight loss trial success boosts obesity drug prospects - AD HOC NEWS
Eli Lilly stock (US5324571083): Long-term weight loss trial success boosts obesity drug prospects AD HOC NEWS
Novo Nordisk Canada and Rexall Pharmacy partner to offer convenience, support, and home delivery for Canadians taking Ozempic® and Wegovy® - PR Newswire Canada
Novo Nordisk Canada and Rexall Pharmacy partner to offer convenience, support, and home delivery for Canadians taking Ozempic® and Wegovy® PR Newswire Canada